<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31364784</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>04</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1529-8019</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>32</Volume>
            <Issue>5</Issue>
            <PubDate>
              <Year>2019</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Dermatologic therapy</Title>
          <ISOAbbreviation>Dermatol Ther</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pachyonychia congenita responding favorably to a combination of surgical and medical therapies.</ArticleTitle>
        <Pagination>
          <StartPage>e13045</StartPage>
          <MedlinePgn>e13045</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/dth.13045</ELocationID>
        <Abstract>
          <AbstractText>Pachyonychia congenital (PC) is a rare genetic disorder of cornification and is classified into five types on the basis of keratin gene involved. There are no established treatment options available for PC. Sirolimus in both topical and oral form has been studied in management of PC. We report a young female with a novel genetic mutation in KRT6A gene who presented with painful palmoplantar hyperkeratosis and onychogryphosis, which was cosmetically disfiguring. She was prescribed oral sirolimus after all investigations. There was significant improvement in pain within a week. Pain relief was sustained at 1 year follow-up with topical treatment only. Serial nail avulsion surgeries were also done with showed significant cosmetic improvement in the nails. Medical therapies can be combined with surgery for a better cosmetic outcome and improvement in patient quality of life.</AbstractText>
          <CopyrightInformation>© 2019 Wiley Periodicals, Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Daroach</LastName>
            <ForeName>Manju</ForeName>
            <Initials>M</Initials>
            <Identifier Source="ORCID">0000-0002-9439-499X</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dogra</LastName>
            <ForeName>Sunil</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bhattacharjee</LastName>
            <ForeName>Rajsmita</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0002-6060-2877</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tp</LastName>
            <ForeName>Afra</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Smith</LastName>
            <ForeName>Frances</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Chief Geneticist, Pachyonychia Congenita Project (PC Project), Holladay, Utah.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Mahajan</LastName>
            <ForeName>Rahul</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016422">Letter</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2019</Year>
          <Month>08</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Dermatol Ther</MedlineTA>
        <NlmUniqueID>9700070</NlmUniqueID>
        <ISSNLinking>1396-0296</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C507569">KRT6A protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D053553">Keratin-6</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009539">Nicotinic Acids</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>81BDR9Y8PS</RegistryNumber>
          <NameOfSubstance UI="C086827">tazarotene</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>O414PZ4LPZ</RegistryNumber>
          <NameOfSubstance UI="D020156">Salicylic Acid</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>W36ZG6FT64</RegistryNumber>
          <NameOfSubstance UI="D020123">Sirolimus</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000287" MajorTopicYN="N">Administration, Topical</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053553" MajorTopicYN="N">Keratin-6</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009262" MajorTopicYN="N">Nails</DescriptorName>
          <QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009539" MajorTopicYN="N">Nicotinic Acids</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D053549" MajorTopicYN="N">Pachyonychia Congenita</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D035583" MajorTopicYN="N">Rare Diseases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020156" MajorTopicYN="N">Salicylic Acid</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020123" MajorTopicYN="N">Sirolimus</DescriptorName>
          <QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">novel mutation</Keyword>
        <Keyword MajorTopicYN="Y">pachyonychia congenita</Keyword>
        <Keyword MajorTopicYN="Y">sirolimus</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>10</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>4</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>8</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31364784</ArticleId>
        <ArticleId IdType="doi">10.1111/dth.13045</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>DeKlotz, C. M. C., Schwartz, M. E., &amp; Milstone, L. M. (2017). Nail removal in pachyonychia congenita: Patient-reported survey outcomes. Journal of American Academy of Dermatology, 76, 990-992.</Citation>
        </Reference>
        <Reference>
          <Citation>Goldberg, I., Fruchter, D., Meilick, A., Schwartz, M. E., &amp; Sprecher, E. (2014). Best treatment practices for pachyonychia congenita. Journal of European Academy of Dermatology &amp; Venereology, 28, 279-285.</Citation>
        </Reference>
        <Reference>
          <Citation>Hickerson, R. P., Leake, D., Pho, L. N., Leachman, S. A., &amp; Kaspar, R. L. (2009). Rapamycin selectively inhibits expression of inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients. Journal of Dermatological Science, 56, 82-88.</Citation>
        </Reference>
        <Reference>
          <Citation>Oji, V., &amp; Metze, D. T. H. (2016). Inherited disorders of cornification: Rook's textbook of dermatology (9th ed.). Wiley blackwell, ISBN 9781118441190.</Citation>
        </Reference>
        <Reference>
          <Citation>Teng, J. M. C., Bartholomew, F. B., &amp; Patel, V. S. G. (2018). Novel treatment of painful plantar keratoderma in pachyonychia congenita using topical sirolimus. Clinical and Experimental Dermatology, 43, 968-971.</Citation>
        </Reference>
        <Reference>
          <Citation>Wilson, N. J., O'Toole, E. A., Milstone, L. M., Hansen, C. D., Shepherd, A. A., Al-Asadi, E., … Smith, F. J. (2014). The molecular genetic analysis of the expanding pachyonychia congenita case collection. British Journal of Dermatology, 171, 343-355.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
